Bruce Carter
Faculty Member
Last active: 4/4/2019

  1. A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G (1996) EMBO J 15(13): 3332-7
    › Primary publication · 8670834 (PubMed) · PMC451896 (PubMed Central)
  2. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Biffo S, Offenhäuser N, Carter BD, Barde YA (1995) Development 121(8): 2461-70
    › Primary publication · 7671810 (PubMed)
  3. Differential regulation of p21ras activation in neurons by nerve growth factor and brain-derived neurotrophic factor. Carter BD, Zirrgiebel U, Barde YA (1995) J Biol Chem 270(37): 21751-7
    › Primary publication · 7665594 (PubMed)
  4. Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Carter BD, Medzihradsky F (1993) Mol Pharmacol 43(3): 465-73
    › Primary publication · 8383804 (PubMed)
  5. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Carter BD, Medzihradsky F (1993) Proc Natl Acad Sci U S A 90(9): 4062-6
    › Primary publication · 8097884 (PubMed) · PMC46446 (PubMed Central)
  6. Opioid signal transduction in intact and fragmented SH-SY5Y neural cells. Carter BD, Medzihradsky F (1992) J Neurochem 58(5): 1611-9
    › Primary publication · 1560222 (PubMed)
  7. Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig. Clark MJ, Carter BD, Medzihradsky F (1988) Eur J Pharmacol 148(3): 343-51
    › Primary publication · 2898375 (PubMed)